Psychedelic therapy is not the right fit for everyone

Screening, and why no is sometimes the caring answer. A practice that offers ketamine-assisted psychotherapy and Spravato has to be willing to say that a given treatment is not right for a given person, and to say it early, at the evaluation, rather than after a disappointing session. Eight seconds, one point.

That is why nothing here starts with a dose. Ketamine and Spravato come after a free consultation, a 90-minute evaluation, a medical and medication review, and a plan built together; Spravato adds the FDA's own monitoring program. The clip is attached to psychedelic integration therapy. For what screening covers, read ketamine-assisted psychotherapy and Spravato treatment. Someone turned down for one option is not turned away; the evaluation usually points to another.

This video is educational and is not medical advice.